Copyright Reports & Markets. All rights reserved.

Global Cyclodextrin in Pharma Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Cyclodextrin in Pharma Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Alpha-Cyclodextrin in Pharma
    • 1.3.3 Beta-Cyclodextrin in Pharma
    • 1.3.4 Gamma-Cyclodextrin in Pharma
    • 1.3.5 CD Derivatives
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Cyclodextrin in Pharma Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Tablets and Capsules
    • 1.4.3 Injectables
  • 1.5 Global Cyclodextrin in Pharma Market Size & Forecast
    • 1.5.1 Global Cyclodextrin in Pharma Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Cyclodextrin in Pharma Sales Quantity (2019-2030)
    • 1.5.3 Global Cyclodextrin in Pharma Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Wacker
    • 2.1.1 Wacker Details
    • 2.1.2 Wacker Major Business
    • 2.1.3 Wacker Cyclodextrin in Pharma Product and Services
    • 2.1.4 Wacker Cyclodextrin in Pharma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Wacker Recent Developments/Updates
  • 2.2 Ensuiko Sugar Refining
    • 2.2.1 Ensuiko Sugar Refining Details
    • 2.2.2 Ensuiko Sugar Refining Major Business
    • 2.2.3 Ensuiko Sugar Refining Cyclodextrin in Pharma Product and Services
    • 2.2.4 Ensuiko Sugar Refining Cyclodextrin in Pharma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Ensuiko Sugar Refining Recent Developments/Updates
  • 2.3 Nihon Shokuhin Kako
    • 2.3.1 Nihon Shokuhin Kako Details
    • 2.3.2 Nihon Shokuhin Kako Major Business
    • 2.3.3 Nihon Shokuhin Kako Cyclodextrin in Pharma Product and Services
    • 2.3.4 Nihon Shokuhin Kako Cyclodextrin in Pharma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Nihon Shokuhin Kako Recent Developments/Updates
  • 2.4 Roquette
    • 2.4.1 Roquette Details
    • 2.4.2 Roquette Major Business
    • 2.4.3 Roquette Cyclodextrin in Pharma Product and Services
    • 2.4.4 Roquette Cyclodextrin in Pharma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Roquette Recent Developments/Updates
  • 2.5 Ashland
    • 2.5.1 Ashland Details
    • 2.5.2 Ashland Major Business
    • 2.5.3 Ashland Cyclodextrin in Pharma Product and Services
    • 2.5.4 Ashland Cyclodextrin in Pharma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Ashland Recent Developments/Updates
  • 2.6 Shandong Xinda
    • 2.6.1 Shandong Xinda Details
    • 2.6.2 Shandong Xinda Major Business
    • 2.6.3 Shandong Xinda Cyclodextrin in Pharma Product and Services
    • 2.6.4 Shandong Xinda Cyclodextrin in Pharma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Shandong Xinda Recent Developments/Updates
  • 2.7 Yunan Yongguang
    • 2.7.1 Yunan Yongguang Details
    • 2.7.2 Yunan Yongguang Major Business
    • 2.7.3 Yunan Yongguang Cyclodextrin in Pharma Product and Services
    • 2.7.4 Yunan Yongguang Cyclodextrin in Pharma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Yunan Yongguang Recent Developments/Updates
  • 2.8 Qufu Tianli
    • 2.8.1 Qufu Tianli Details
    • 2.8.2 Qufu Tianli Major Business
    • 2.8.3 Qufu Tianli Cyclodextrin in Pharma Product and Services
    • 2.8.4 Qufu Tianli Cyclodextrin in Pharma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Qufu Tianli Recent Developments/Updates
  • 2.9 Zibo Qianhui
    • 2.9.1 Zibo Qianhui Details
    • 2.9.2 Zibo Qianhui Major Business
    • 2.9.3 Zibo Qianhui Cyclodextrin in Pharma Product and Services
    • 2.9.4 Zibo Qianhui Cyclodextrin in Pharma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Zibo Qianhui Recent Developments/Updates
  • 2.10 Jiangsu Fengyuan
    • 2.10.1 Jiangsu Fengyuan Details
    • 2.10.2 Jiangsu Fengyuan Major Business
    • 2.10.3 Jiangsu Fengyuan Cyclodextrin in Pharma Product and Services
    • 2.10.4 Jiangsu Fengyuan Cyclodextrin in Pharma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Jiangsu Fengyuan Recent Developments/Updates
  • 2.11 Mengzhou Huaxing
    • 2.11.1 Mengzhou Huaxing Details
    • 2.11.2 Mengzhou Huaxing Major Business
    • 2.11.3 Mengzhou Huaxing Cyclodextrin in Pharma Product and Services
    • 2.11.4 Mengzhou Huaxing Cyclodextrin in Pharma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Mengzhou Huaxing Recent Developments/Updates
  • 2.12 Mengzhou Hongji
    • 2.12.1 Mengzhou Hongji Details
    • 2.12.2 Mengzhou Hongji Major Business
    • 2.12.3 Mengzhou Hongji Cyclodextrin in Pharma Product and Services
    • 2.12.4 Mengzhou Hongji Cyclodextrin in Pharma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Mengzhou Hongji Recent Developments/Updates

3 Competitive Environment: Cyclodextrin in Pharma by Manufacturer

  • 3.1 Global Cyclodextrin in Pharma Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Cyclodextrin in Pharma Revenue by Manufacturer (2019-2024)
  • 3.3 Global Cyclodextrin in Pharma Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Cyclodextrin in Pharma by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Cyclodextrin in Pharma Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Cyclodextrin in Pharma Manufacturer Market Share in 2023
  • 3.5 Cyclodextrin in Pharma Market: Overall Company Footprint Analysis
    • 3.5.1 Cyclodextrin in Pharma Market: Region Footprint
    • 3.5.2 Cyclodextrin in Pharma Market: Company Product Type Footprint
    • 3.5.3 Cyclodextrin in Pharma Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Cyclodextrin in Pharma Market Size by Region
    • 4.1.1 Global Cyclodextrin in Pharma Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Cyclodextrin in Pharma Consumption Value by Region (2019-2030)
    • 4.1.3 Global Cyclodextrin in Pharma Average Price by Region (2019-2030)
  • 4.2 North America Cyclodextrin in Pharma Consumption Value (2019-2030)
  • 4.3 Europe Cyclodextrin in Pharma Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Cyclodextrin in Pharma Consumption Value (2019-2030)
  • 4.5 South America Cyclodextrin in Pharma Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Cyclodextrin in Pharma Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Cyclodextrin in Pharma Sales Quantity by Type (2019-2030)
  • 5.2 Global Cyclodextrin in Pharma Consumption Value by Type (2019-2030)
  • 5.3 Global Cyclodextrin in Pharma Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Cyclodextrin in Pharma Sales Quantity by Application (2019-2030)
  • 6.2 Global Cyclodextrin in Pharma Consumption Value by Application (2019-2030)
  • 6.3 Global Cyclodextrin in Pharma Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Cyclodextrin in Pharma Sales Quantity by Type (2019-2030)
  • 7.2 North America Cyclodextrin in Pharma Sales Quantity by Application (2019-2030)
  • 7.3 North America Cyclodextrin in Pharma Market Size by Country
    • 7.3.1 North America Cyclodextrin in Pharma Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Cyclodextrin in Pharma Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Cyclodextrin in Pharma Sales Quantity by Type (2019-2030)
  • 8.2 Europe Cyclodextrin in Pharma Sales Quantity by Application (2019-2030)
  • 8.3 Europe Cyclodextrin in Pharma Market Size by Country
    • 8.3.1 Europe Cyclodextrin in Pharma Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Cyclodextrin in Pharma Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Cyclodextrin in Pharma Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Cyclodextrin in Pharma Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Cyclodextrin in Pharma Market Size by Region
    • 9.3.1 Asia-Pacific Cyclodextrin in Pharma Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Cyclodextrin in Pharma Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Cyclodextrin in Pharma Sales Quantity by Type (2019-2030)
  • 10.2 South America Cyclodextrin in Pharma Sales Quantity by Application (2019-2030)
  • 10.3 South America Cyclodextrin in Pharma Market Size by Country
    • 10.3.1 South America Cyclodextrin in Pharma Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Cyclodextrin in Pharma Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Cyclodextrin in Pharma Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Cyclodextrin in Pharma Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Cyclodextrin in Pharma Market Size by Country
    • 11.3.1 Middle East & Africa Cyclodextrin in Pharma Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Cyclodextrin in Pharma Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Cyclodextrin in Pharma Market Drivers
  • 12.2 Cyclodextrin in Pharma Market Restraints
  • 12.3 Cyclodextrin in Pharma Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Cyclodextrin in Pharma and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Cyclodextrin in Pharma
  • 13.3 Cyclodextrin in Pharma Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Cyclodextrin in Pharma Typical Distributors
  • 14.3 Cyclodextrin in Pharma Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Cyclodextrins are a family of cyclic oligosaccharides, consisting of a macrocyclic ring of glucose subunits joined by α-1,4 glycosidic bonds. Cyclodextrins are produced from starch by enzymatic conversion. They are used in food, pharmaceutical, drug delivery, and chemical industries, as well as agriculture and environmental engineering.
    According to our (Global Info Research) latest study, the global Cyclodextrin in Pharma market size was valued at US$ 36.8 million in 2023 and is forecast to a readjusted size of USD 57.1 million by 2030 with a CAGR of 6.5% during review period.
    Global key manufacturers of cyclodextrin in pharma include Wacker, Ensuiko Sugar Refining, Ashland, etc. Global top 3 manufacturers hold a share above 60%. Europe and North America are the major producing regions in the world, followed by China and Japan. In terms of application, the product is most widely used in tablets and capsules, followed by injectables.
    This report is a detailed and comprehensive analysis for global Cyclodextrin in Pharma market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Cyclodextrin in Pharma market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2019-2030
    Global Cyclodextrin in Pharma market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2019-2030
    Global Cyclodextrin in Pharma market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2019-2030
    Global Cyclodextrin in Pharma market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/MT), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Cyclodextrin in Pharma
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Cyclodextrin in Pharma market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Wacker, Ensuiko Sugar Refining, Nihon Shokuhin Kako, Roquette, Ashland, Shandong Xinda, Yunan Yongguang, Qufu Tianli, Zibo Qianhui, Jiangsu Fengyuan, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Cyclodextrin in Pharma market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Alpha-Cyclodextrin in Pharma
    Beta-Cyclodextrin in Pharma
    Gamma-Cyclodextrin in Pharma
    CD Derivatives
    Market segment by Application
    Tablets and Capsules
    Injectables
    Major players covered
    Wacker
    Ensuiko Sugar Refining
    Nihon Shokuhin Kako
    Roquette
    Ashland
    Shandong Xinda
    Yunan Yongguang
    Qufu Tianli
    Zibo Qianhui
    Jiangsu Fengyuan
    Mengzhou Huaxing
    Mengzhou Hongji
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Cyclodextrin in Pharma product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Cyclodextrin in Pharma, with price, sales quantity, revenue, and global market share of Cyclodextrin in Pharma from 2019 to 2024.
    Chapter 3, the Cyclodextrin in Pharma competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Cyclodextrin in Pharma breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Cyclodextrin in Pharma market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Cyclodextrin in Pharma.
    Chapter 14 and 15, to describe Cyclodextrin in Pharma sales channel, distributors, customers, research findings and conclusion.

    Buy now